Successfully conducted E&Y cGMP audit in May 2018.    2D barcode printing on all products implemented from May 2018.   Received ISO 9001:2015 Certification in July 2018.   Received ISO 14001:2015 Certification in December 2019.   Received ISO 45001:2018 Certification in December 2020.

Ceflaro

Brand Name

Ceflaro

Generic Name

Ceftaroline

Composition

Ceflaro 400mg IV Injection:
Each vial contains Ceftaroline Fosamil Monoacetate Monohydrate Equivalent to Ceftaroline Fosamil 400mg (with L-Arginine).

Ceflaro 600mg IV Injection:
Each vial contains Cef taroline Fosamil Monoacetate Monohydrate Equivalent to Ceftaroline Fosamil 600mg (with L-Arginine).

Description

Ceflaro (Ceftaroline Fosamil) for injection, is a sterile, semi-synthetic, prodrug of the cephalosporin antibacterial class of beta-lactams (β-lactams) for intravenous use.

Indications

Ceftaroline has been shown to be active against most of the following bacteria, both in vitro and in clinical infections:

Skin Infection:

Gram-positive Bacteria: Staphylococcus aureus (including methicillin-susceptible and-resistant isolates), Streptococcus pyogenes and Streptococcus agalactiae.

Gram-negative Bacteria: Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.

Community-Acquired Bacterial Pneumonia (CABP):

Gram-positive Bacteria: Streptococcus pneumoniae and Staphylococcus aureus (methicillin-susceptible isolates only).

Gram-negative Bacteria: Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella oxytoca and Escherichia coli.

Presentation

Ceflaro 600mg IV Injection: 1 vial of 600mg Ceftaroline Fosamil and 1 ampoule of 20mL sterile water for injection.

Ceflaro 400mg IV Injection: 1 vial of 400mg Ceftaroline Fosamil and 1 ampoule of 20mL sterile water for injection

Product Information Leaflets